SCHEMBL23584740

SCHEMBL23584740

CSc1ncnn2c([C@H]3CC[C@@H](CN4CCC(F)(F)C[C@H]4CCNC(=O)OC(C)(C)C)O3)ccc12

nearest known ligand 0.30

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ SIRT2 Q8IXJ6 1/20 0.30
▸ SIRT1 Q96EB6 1/20 0.30
▸ SIRT3 Q9NTG7 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23584607 0.93 — —
SCHEMBL23584694 0.90 CSNK2A2 (0.34) SIRT2SIRT1SIRT3
SCHEMBL23584485 0.87 BRD4 (0.33) SIRT2SIRT1SIRT3
SCHEMBL19344067 0.84 — —
SCHEMBL23584486 0.83 DOT1L (0.33) —
SCHEMBL23584749 0.81 BRD4 (0.31) —
SCHEMBL23584789 0.80 — —
SCHEMBL23584487 0.80 — —
SCHEMBL22435097 0.78 — —
SCHEMBL19344074 0.78 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3426664-B1 SUBSTITUTED NUCLEOSIDE ANALOGUES FOR USE AS PRMT5 INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2021-06-30 — — EP disclosed
Send feedback